-
1
The known genetic variants of BRCA1, BRCA2 and NOD2 in pancreatitis and pancreatic cancer risk assessment
Published 2025-01-01Subjects: “…BRCA1…”
Get full text
Article -
2
Low dose DNA methyltransferase inhibitors potentiate PARP inhibitors in homologous recombination repair deficient tumors
Published 2025-01-01Subjects: “…BRCA1…”
Get full text
Article -
3
Personality traits of women with hereditary risk for breast/ovarian cancer versus obstetric history and cancer preventive behaviors
Published 2025-01-01Subjects: Get full text
Article -
4
-
5
Navigating complex choices through legitimation: Narrative strategies in risk-reduction mastectomy decision-making among unaffected women with genetic risk for breast cancer in Swi...
Published 2025-06-01Subjects: “…BRCA1 and BRCA2…”
Get full text
Article -
6
-
7
Cardiovascular health in breast cancer patients: insight on BRCA1/2 mutations impact
Published 2025-01-01Subjects: Get full text
Article -
8
BRCA1 is involved in sustaining rapid antler growth possibly via balancing of the p53/endoplasmic reticulum stress signaling pathway
Published 2025-01-01Subjects: Get full text
Article -
9
Integrating BRCA testing into routine prostate cancer care: a multidisciplinary approach by SIUrO and other Italian Scientific Societies
Published 2025-01-01Subjects: “…BRCA…”
Get full text
Article -
10
Los olvidados: Non-BRCA variants associated with Hereditary breast cancer in Mexican population
Published 2025-01-01Subjects: “…Non-BRCA…”
Get full text
Article -
11
Case report: Deciphering the clinical significance of a novel partial BRCA1 exon 10 duplication in a patient with triple-negative breast cancer
Published 2025-02-01Subjects: Get full text
Article -
12
Homologous recombination deficiency test validation in patients with high-grade advanced ovarian cancer
Published 2025-02-01Subjects: Get full text
Article -
13
-
14
Prognostic factors in hereditary breast cancer: A review
Published 2024-08-01Subjects: Get full text
Article -
15
-
16
PARP inhibitor‐based treatment in metastatic, castration‐resistant prostate cancer (mCRPC): A systematic review and meta‐analysis
Published 2025-01-01Subjects: Get full text
Article